Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis

4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to estab...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenchang Yang, Yaxin Wang, Peng Zhang, Tao Wang, Chengguo Li, Xin Tong, Xiangyu Zeng, Yuping Yin, Kaixiong Tao, Ruidong Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/5766434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563892946993152
author Wenchang Yang
Yaxin Wang
Peng Zhang
Tao Wang
Chengguo Li
Xin Tong
Xiangyu Zeng
Yuping Yin
Kaixiong Tao
Ruidong Li
author_facet Wenchang Yang
Yaxin Wang
Peng Zhang
Tao Wang
Chengguo Li
Xin Tong
Xiangyu Zeng
Yuping Yin
Kaixiong Tao
Ruidong Li
author_sort Wenchang Yang
collection DOAJ
description 4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to establish an AIH-associated liver injury model. Furthermore, we investigated the effect of OI in Con A-induced liver injury and found that OI mitigated Con A-induced histopathological damage. OI administration reduced serum levels of alanine transaminase and aspartate transaminase in Con A-treated mice and attenuated the infiltration of macrophages induced by Con A. Moreover, OI effectively inhibited the expression of proinflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and IL-1β induced by Con A. Furthermore, OI decreased hepatocyte apoptosis and malondialdehyde levels and increased the reduced glutathione/oxidized glutathione ratio in the Con A-induced liver injury model. In addition, we found that OI inhibited Con A-induced hepatocyte apoptosis in vitro, while Nrf2 deletion eliminated this effect. Furthermore, we administrated the Nrf2 inhibitor ML385 in OI+Con A-treated mice and found that ML385 eliminated the protective effect of OI in vivo. In addition, OI inhibited Con A-induced activation of nuclear factor-kappa B (NF-𝜅B) and the expression of proinflammatory cytokines in macrophages. Therefore, OI protected mice from Con A-induced liver damage and may be associated with Nrf2 activation and NF-𝜅B inhibition. Finally, our study revealed that OI inhibited TNF-α, or supernatants from Con A-treated RAW264.7 cells induced hepatocyte apoptosis. In conclusion, our study indicated that OI alleviated Con A-induced hepatic damage by reducing inflammatory response, oxidative stress, and apoptosis.
format Article
id doaj-art-20bdf1b4c4154231b1269b73bde01315
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-20bdf1b4c4154231b1269b73bde013152025-02-03T01:12:14ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/5766434Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune HepatitisWenchang Yang0Yaxin Wang1Peng Zhang2Tao Wang3Chengguo Li4Xin Tong5Xiangyu Zeng6Yuping Yin7Kaixiong Tao8Ruidong Li9Department of Gastrointestinal SurgeryDepartment of Critical Care MedicineDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal Surgery4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to establish an AIH-associated liver injury model. Furthermore, we investigated the effect of OI in Con A-induced liver injury and found that OI mitigated Con A-induced histopathological damage. OI administration reduced serum levels of alanine transaminase and aspartate transaminase in Con A-treated mice and attenuated the infiltration of macrophages induced by Con A. Moreover, OI effectively inhibited the expression of proinflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and IL-1β induced by Con A. Furthermore, OI decreased hepatocyte apoptosis and malondialdehyde levels and increased the reduced glutathione/oxidized glutathione ratio in the Con A-induced liver injury model. In addition, we found that OI inhibited Con A-induced hepatocyte apoptosis in vitro, while Nrf2 deletion eliminated this effect. Furthermore, we administrated the Nrf2 inhibitor ML385 in OI+Con A-treated mice and found that ML385 eliminated the protective effect of OI in vivo. In addition, OI inhibited Con A-induced activation of nuclear factor-kappa B (NF-𝜅B) and the expression of proinflammatory cytokines in macrophages. Therefore, OI protected mice from Con A-induced liver damage and may be associated with Nrf2 activation and NF-𝜅B inhibition. Finally, our study revealed that OI inhibited TNF-α, or supernatants from Con A-treated RAW264.7 cells induced hepatocyte apoptosis. In conclusion, our study indicated that OI alleviated Con A-induced hepatic damage by reducing inflammatory response, oxidative stress, and apoptosis.http://dx.doi.org/10.1155/2022/5766434
spellingShingle Wenchang Yang
Yaxin Wang
Peng Zhang
Tao Wang
Chengguo Li
Xin Tong
Xiangyu Zeng
Yuping Yin
Kaixiong Tao
Ruidong Li
Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
Mediators of Inflammation
title Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
title_full Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
title_fullStr Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
title_full_unstemmed Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
title_short Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
title_sort hepatoprotective role of 4 octyl itaconate in concanavalin a induced autoimmune hepatitis
url http://dx.doi.org/10.1155/2022/5766434
work_keys_str_mv AT wenchangyang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT yaxinwang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT pengzhang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT taowang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT chengguoli hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT xintong hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT xiangyuzeng hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT yupingyin hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT kaixiongtao hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis
AT ruidongli hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis